1. Chairman’s Address

   Session I: Prevalence and Risk Factors 01 December 2012 Pages: 1 - 1

2. Blood Pressure in Middle-Aged People in Albury and Melbourne — Implications for Screening

   • R. R. H. Lovell

   Session I: Prevalence and Risk Factors 01 December 2012 Pages: 2 - 5

3. Borderline Hypertension Discovered During Screening: Effect of Twelve Months’ Treatment

   • M. G. McCall
   • M. L. Lamb
   • N. S. Stenhouse

   Session I: Prevalence and Risk Factors 01 December 2012 Pages: 6 - 11

4. The Prevalence of Hypertension in the United States Today

   • D. R. Labarthe

   Session I: Prevalence and Risk Factors 01 December 2012 Pages: 11 - 15

5. Morbidity and Mortality in Hypertension

   • A. E. Doyle

   Session II: Morbidity and Mortality 01 December 2012 Pages: 25 - 27

6. Hypertension and Strokes

   • J. L. Corbett

   Session II: Morbidity and Mortality 01 December 2012 Pages: 27 - 34

7. Morbidity and Mortality in Untreated and Treated Hypertension: Results from the Göteborg 50- year- old Men Study

   • K. Svärdsudd
   • G. Berglund
   • G. Tibblin

   Session II: Morbidity and Mortality 01 December 2012 Pages: 34 - 38

8. Mortality Patterns in Treated Hypertension: Results from Sydney Hospital

   • G. E. Bauer

   Session II: Morbidity and Mortality 01 December 2012 Pages: 39 - 44

9. Recent Trends in Mortality at the Dunedin Hypertension Clinic

   • F. O. Simpson

   Session II: Morbidity and Mortality 01 December 2012 Pages: 45 - 47

10. New Instruments for Measuring Blood Pressure

    • D. R. Labarthe

    Session III: Measurement of Blood Pressure and Pre-Treatment Work-Up 01 December 2012 Pages: 48 - 57

11. Pre-Treatment Workup for Antihypertensive Treatment

    • G. Berglund

    Session III: Measurement of Blood Pressure and Pre-Treatment Work-Up 01 December 2012 Pages: 60 - 65

12. The Kidney and Antihypertensive Therapy

    • R. R. Bailey

    Session IV: Problems in the Management of Hypertension 01 December 2012 Pages: 70 - 77

13. The Treatment of Resistant Hypertension

    • Priscilla S. Kincaid-Smith

    Session IV: Problems in the Management of Hypertension 01 December 2012 Pages: 78 - 86

14. The Problem of Non-Compliance in Long-Term Antihypertensive Therapy

    • J. D. Abernethy

    Session IV: Problems in the Management of Hypertension 01 December 2012 Pages: 86 - 90

15. Adverse Drug Reactions During Treatment of Hypertension

    • G. S. M. Kellaway

    Session IV: Problems in the Management of Hypertension 01 December 2012 Pages: 91 - 99

16. Some Aspects of the Pharmacology of β-Adrenoreceptor Blockers

    • B. Åblad
    • E. Carlsson
    • L. Ek

    Session V: Pharmacology of β-Adrenoreceptor Blocking Drugs 01 December 2012 Pages: 100 - 111

17. Clinical Pharmacokinetics ofβ-Adrenoreceptor Blockers

    • G. Johnsson
    • C. -G. Regårdh

    Session V: Pharmacology of β-Adrenoreceptor Blocking Drugs 01 December 2012 Pages: 111 - 121

18. Metabolic Effects ofβ-Adrenoreceptor Blockers

    • Hendrika J. Waal-Manning

    Session V: Pharmacology of β-Adrenoreceptor Blocking Drugs 01 December 2012 Pages: 121 - 126

19. Haemodynamic Effects of β-Adrenoreceptor Blockers in Hypertension

    • B. Åblad
    • B. Ljung
    • R. Sannerstedt

    Session VI: Mode of Action of β-Adrenoreceptor Blockers in Hypertension 01 December 2012 Pages: 127 - 134

20. Effects of β-Adrenoreceptor Blocking Drugs on Adrenergic Transmission

    • M. J. Rand
    • M. Law
    • M. W. McCulloch

    Session VI: Mode of Action of β-Adrenoreceptor Blockers in Hypertension 01 December 2012 Pages: 134 - 143

21. Action of Propranolol on Arterial Pressure and on Cardiovascular Reflexes

    • P. I. Korner
    • W. P. Anderson
    • A. Bobik

    Session VI: Mode of Action of β-Adrenoreceptor Blockers in Hypertension 01 December 2012 Pages: 143 - 150

22. The Role of Renin in the Antihypertensive Action of β-Adrenoreceptor Blocking Agents

    • G. S. Stokes
    • R. M. Graham
    • M. A. Weber

    Session VI: Mode of Action of β-Adrenoreceptor Blockers in Hypertension 01 December 2012 Pages: 150 - 156

23. Effects of β-Adrenoreceptor Blocking Drugs on Plasma Volume, Renin and Aldosterone as Components of Their Antihypertensive Action

    • R. D. Gordon

    Session VI: Mode of Action of β-Adrenoreceptor Blockers in Hypertension 01 December 2012 Pages: 156 - 163

24. Experience with β-Adrenoreceptor Blockers in Hypertension

    • Hendrika J. Waal-Manning

    Session VII: Use of β-Adrenoreceptor Blocking Drugs in Hypertension 01 December 2012 Pages: 164 - 171

25. Use of β-Adrenoreceptor Blockers in Combination with β-Stimulators in Patients with Obstructive Lung Disease

    • G. Johnsson

    Session VII: Use of β-Adrenoreceptor Blocking Drugs in Hypertension 01 December 2012 Pages: 171 - 177

26. Clinical and Haemodynamic Effects of Minoxidil in Refractory Hypertension

    • R. Zacest
    • D. B. Frewin
    • B. Jackson

    Session VII: Use of β-Adrenoreceptor Blocking Drugs in Hypertension 01 December 2012 Pages: 177 - 184

27. Effect of β-Adrenoreceptor Blockers on Heart Rate and Blood Pressure in Dynamic and Isometric Exercise

    • G. Nyberg

    Session VII: Use of β-Adrenoreceptor Blocking Drugs in Hypertension 01 December 2012 Pages: 185 - 195

28. Session VIII: General Discussion on the Place of β-Adrenoreceptor Blockers in Hypertension

    OriginalPaper 01 December 2012 Pages: 196 - 204